These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 30380949)

  • 1. The relationship between smoking, psoriasis and psoriatic arthritis.
    Pezzolo E; Naldi L
    Expert Rev Clin Immunol; 2019 Jan; 15(1):41-48. PubMed ID: 30380949
    [No Abstract]   [Full Text] [Related]  

  • 2. Cardiovascular comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
    Armstrong AW; Gelfand JM; Boehncke WH; Armstrong EJ
    J Rheumatol; 2013 Aug; 40(8):1434-7. PubMed ID: 23908540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between metabolic syndrome and carotid intima-media thickness: cross-sectional comparison between psoriasis and psoriatic arthritis.
    Lin YC; Dalal D; Churton S; Brennan DM; Korman NJ; Kim ES; Husni ME
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):97-103. PubMed ID: 23983044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of biologic agents and other disease-modifying antirheumatic drugs on cardiovascular outcomes in psoriasis and psoriatic arthritis: a systematic review.
    Armstrong AW; Brezinski EA; Follansbee MR; Armstrong EJ
    Curr Pharm Des; 2014; 20(4):500-12. PubMed ID: 23565631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Beyond skin deep: addressing comorbidities in psoriasis.
    Kovitwanichkanont T; Chong AH; Foley P
    Med J Aust; 2020 Jun; 212(11):528-534. PubMed ID: 32388913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of tumour necrosis factor inhibitors, methotrexate, non-steroidal anti-inflammatory drugs and corticosteroids on cardiovascular events in rheumatoid arthritis, psoriasis and psoriatic arthritis: a systematic review and meta-analysis.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    Ann Rheum Dis; 2015 Mar; 74(3):480-9. PubMed ID: 25561362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The impact of smoking on prevalence of psoriasis and psoriatic arthritis.
    Gazel U; Ayan G; Solmaz D; Akar S; Aydin SZ
    Rheumatology (Oxford); 2020 Oct; 59(10):2695-2710. PubMed ID: 32500136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Risk of Systemic Diseases in Those with Psoriasis and Psoriatic Arthritis: From Mechanisms to Clinic.
    Woo YR; Park CJ; Kang H; Kim JE
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cardiovascular and other comorbidities in patients with psoriatic arthritis: a comparison with patients with psoriasis.
    Husted JA; Thavaneswaran A; Chandran V; Eder L; Rosen CF; Cook RJ; Gladman DD
    Arthritis Care Res (Hoboken); 2011 Dec; 63(12):1729-35. PubMed ID: 21905258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
    Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
    J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psoriatic arthritis onset in psoriatic patients receiving UV phototherapy in Italy.
    Balato A; Caiazzo G; Balato N; Napolitano M;
    G Ital Dermatol Venereol; 2020 Dec; 155(6):733-738. PubMed ID: 30251803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infectious, oncologic, and autoimmune comorbidities of psoriasis and psoriatic arthritis: a report from the GRAPPA 2012 annual meeting.
    Armstrong AW; Coates LC; Espinoza LR; Ogdie AR; Rich P; Soriano ER
    J Rheumatol; 2013 Aug; 40(8):1438-41. PubMed ID: 23908541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TNF alpha inhibitors in the treatment of psoriasis and psoriatic arthritis.
    Tobin AM; Kirby B
    BioDrugs; 2005; 19(1):47-57. PubMed ID: 15691217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exploring priority research areas in psoriasis and psoriatic arthritis from dermatologists' perspective: a report from the GRAPPA 2011 annual meeting.
    Armstrong AW; Callis Duffin K; Garg A; Gelfand JM; Gottlieb AB; Krueger GG; Qureshi AA; Rosen CF
    J Rheumatol; 2012 Nov; 39(11):2204-10. PubMed ID: 23118289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardiometabolic Comorbidities in Psoriasis and Psoriatic Arthritis.
    Puig L
    Int J Mol Sci; 2017 Dec; 19(1):. PubMed ID: 29295598
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A systematic review of herpes zoster incidence and consensus recommendations on vaccination in adult patients on systemic therapy for psoriasis or psoriatic arthritis: From the Medical Board of the National Psoriasis Foundation.
    Baumrin E; Van Voorhees A; Garg A; Feldman SR; Merola JF
    J Am Acad Dermatol; 2019 Jul; 81(1):102-110. PubMed ID: 30885757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive treatment of psoriatic arthritis: managing comorbidities and extraarticular manifestations.
    Ogdie A; Schwartzman S; Eder L; Maharaj AB; Zisman D; Raychaudhuri SP; Reddy SM; Husni E
    J Rheumatol; 2014 Nov; 41(11):2315-22. PubMed ID: 25362717
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Smoking paradox in the development of psoriatic arthritis among patients with psoriasis: a population-based study.
    Nguyen UDT; Zhang Y; Lu N; Louie-Gao Q; Niu J; Ogdie A; Gelfand JM; LaValley MP; Dubreuil M; Sparks JA; Karlson EW; Choi HK
    Ann Rheum Dis; 2018 Jan; 77(1):119-123. PubMed ID: 29102956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular comorbidities in psoriasis and psoriatic arthritis: pathogenesis, consequences for patient management, and future research agenda: a report from the GRAPPA 2009 annual meeting.
    Boehncke WH; Gladman DD; Chandran V
    J Rheumatol; 2011 Mar; 38(3):567-71. PubMed ID: 21362790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiovascular disease and risk factors in patients with psoriasis and psoriatic arthritis.
    Tobin AM; Veale DJ; Fitzgerald O; Rogers S; Collins P; O'Shea D; Kirby B
    J Rheumatol; 2010 Jul; 37(7):1386-94. PubMed ID: 20472927
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.